712 related articles for article (PubMed ID: 15183900)
1. Optimizing platelet transfusion therapy.
Heal JM; Blumberg N
Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
[TBL] [Abstract][Full Text] [Related]
2. Current status of leukocyte and platelet administration in cancer therapy.
Walker EM; Cannon A; Mitchum EN
Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
[TBL] [Abstract][Full Text] [Related]
3. Platelet transfusion therapy.
Slichter SJ
Hematol Oncol Clin North Am; 2007 Aug; 21(4):697-729, vii. PubMed ID: 17666286
[TBL] [Abstract][Full Text] [Related]
4. ABO incompatible platelets: risks versus benefit.
Dunbar NM; Ornstein DL; Dumont LJ
Curr Opin Hematol; 2012 Nov; 19(6):475-9. PubMed ID: 22914587
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
[TBL] [Abstract][Full Text] [Related]
6. [Transfusion of platelet concentrates].
Rieux C; Lee K; Lavaud A; Bierling P
Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic platelet transfusions.
Cid J; Escolar G; Lozano M
N Engl J Med; 2010 Jun; 362(22):2140; author reply 2141-2. PubMed ID: 20519690
[No Abstract] [Full Text] [Related]
8. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit.
Vamvakas EC; Hitzler WE
Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342
[TBL] [Abstract][Full Text] [Related]
9. Refractory response to platelet transfusion therapy.
Eisenberg S
J Infus Nurs; 2010; 33(2):89-97. PubMed ID: 20228646
[TBL] [Abstract][Full Text] [Related]
10. Use of platelets in transfusion medicine.
Brubaker DB
J Am Osteopath Assoc; 1989 Dec; 89(12):1553-9. PubMed ID: 2621122
[TBL] [Abstract][Full Text] [Related]
11. [Can thrombocyte crossmatching improve the efficiency of platelet transfusion?].
Weisbach V; Zeiler T; Zingsem J; Musch R; Heuft HG; Eckstein R
Beitr Infusionsther; 1990; 26():160-2. PubMed ID: 1703820
[TBL] [Abstract][Full Text] [Related]
12. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
13. Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs.
Julmy F; Ammann RA; Taleghani BM; Fontana S; Hirt A; Leibundgut K
Transfusion; 2009 Jan; 49(1):21-33. PubMed ID: 18774963
[TBL] [Abstract][Full Text] [Related]
14. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.
Snyder E; McCullough J; Slichter SJ; Strauss RG; Lopez-Plaza I; Lin JS; Corash L; Conlan MG;
Transfusion; 2005 Dec; 45(12):1864-75. PubMed ID: 16371039
[TBL] [Abstract][Full Text] [Related]
15. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
[TBL] [Abstract][Full Text] [Related]
16. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
Slichter SJ
J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
[TBL] [Abstract][Full Text] [Related]
17. Platelet utilization and the transfusion trigger: a prospective analysis.
Greeno E; McCullough J; Weisdorf D
Transfusion; 2007 Feb; 47(2):201-5. PubMed ID: 17302764
[TBL] [Abstract][Full Text] [Related]
18. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
[TBL] [Abstract][Full Text] [Related]
19. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
[TBL] [Abstract][Full Text] [Related]
20. Consensus and controversies in platelet transfusion.
Marwaha N; Sharma RR
Transfus Apher Sci; 2009 Oct; 41(2):127-33. PubMed ID: 19717344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
